UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 114

Sortiert nach

Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder

The Journal of pharmacology and experimental therapeutics, 2012-08, Vol.342 (2), p.429

2012

Link zum Volltext

Verfügbarkeit prüfen

Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients

Journal of Alzheimer's disease, 2017-01, Vol.57 (2), p.557

2017

Link zum Volltext

Verfügbarkeit prüfen

A Data-Dependent Approach to Modeling Volatility in Financial Time Series

Sankhyā. Series B (2008), 2015-05, Vol.77 (1), p.1-26

2015

Link zum Volltext

Verfügbarkeit prüfen

Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease

Journal of Alzheimer's disease, 2016-01, Vol.49 (4), p.1123

2016

Link zum Volltext

Verfügbarkeit prüfen

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease

Journal of Alzheimer's disease, 2016-10, Vol.54 (4), p.1509

2016

Link zum Volltext

Verfügbarkeit prüfen

On the efficiency of a semi-parametric GARCH model

The econometrics journal, 2011-07, Vol.14 (2), p.257-277

2011

Link zum Volltext

Verfügbarkeit prüfen

Effects of Meal Size on the Release of GLP-1 and PYY After Roux-en-Y Gastric Bypass Surgery in Obese Subjects With or Without Type 2 Diabetes

Obesity surgery, 2014-11, Vol.24 (11), p.1969-1974

2014

Link zum Volltext

Verfügbarkeit prüfen

One-step Semiparametric Estimation of the GARCH Model

Journal of financial econometrics, 2014-04, Vol.12 (2), p.382-407

2014

Link zum Volltext

Verfügbarkeit prüfen

Continuous event monitoring via a Bayesian predictive approach

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2016-03, Vol.15 (2), p.109-122

2016

Link zum Volltext

Verfügbarkeit prüfen

P2‐157: The impact of reference region on the variance of estimated change in PET amyloid standard uptake value ratios measured longitudinally in summit and acction

Alzheimer's & dementia, 2015-07, Vol.11 (7S_Part_12), p.P547-P548

2015

Link zum Volltext

Verfügbarkeit prüfen

IC‐P‐037: EVALUATION OF CEREBRAL GRAY MATTER AND PONS AS REFERENCE REGIONS FOR AMYLOID PET: RESULTS FROM A BAPINEUZUMAB SUBCUTANEOUS PHASE 2 TRIAL

Alzheimer's & dementia, 2014-07, Vol.10 (4S_Part_6), p.P23-P23

2014

Link zum Volltext

Verfügbarkeit prüfen

EVALUATION OF CEREBRAL GRAY MATTER AND PONS AS REFERENCE REGIONS FOR AMYLOID PET: RESULTS FROM A BAPINEUZUMAB SUBCUTANEOUS PHASE 2 TRIAL

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P23-P23

2014

Link zum Volltext

Verfügbarkeit prüfen

IC‐P‐041: EFFICACY AND SAFETY OF MONTHLY SUBCUTANEOUS BAPINEUZUMAB

Alzheimer's & dementia, 2014-07, Vol.10 (4S_Part_6), p.P25-P25

2014

Link zum Volltext

Verfügbarkeit prüfen

EFFICACY AND SAFETY OF MONTHLY SUBCUTANEOUS BAPINEUZUMAB

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P25-P25

2014

Link zum Volltext

Verfügbarkeit prüfen

P4‐140: AMYLOID BURDEN‐RELATED PERFORMANCE DIFFERENCES ON COGNITIVE AND FUNCTIONAL INSTRUMENTS ACROSS ALZHEIMER'S DISEASE PATHOPHYSIOLOGIC STAGES

Alzheimer's & dementia, 2014-07, Vol.10, p.P839-P839

2014

Link zum Volltext

Verfügbarkeit prüfen

EFFICACY AND SAFETY OF MONTHLY SUBCUTANEOUS BAPINEUZUMAB

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P446-P447

2014

Link zum Volltext

Verfügbarkeit prüfen

P4‐140: AMYLOID BURDEN‐RELATED PERFORMANCE DIFFERENCES ON COGNITIVE AND FUNCTIONAL INSTRUMENTS ACROSS ALZHEIMER'S DISEASE PATHOPHYSIOLOGIC STAGES

Alzheimer's & dementia, 2014-07, Vol.10 (4S_Part_23)

2014

Link zum Volltext

Verfügbarkeit prüfen

IC‐P‐042: RATES OF CHANGE IN BRAIN VOLUME WITH SUBCUTANEOUS BAPINEUZUMAB

Alzheimer's & dementia, 2014-07, Vol.10 (4S_Part_6), p.P25-P26

2014

Link zum Volltext

Verfügbarkeit prüfen

P1‐362: EFFICACY AND SAFETY OF MONTHLY SUBCUTANEOUS BAPINEUZUMAB

Alzheimer's & dementia, 2014-07, Vol.10 (4S_Part_11), p.P446-P447

2014

Link zum Volltext

Verfügbarkeit prüfen

O4‐04‐04: Pooled biomarker analyses of phase 2 studies of vanutide cridificar vaccine (ACC‐001) in mild‐to‐moderate and early Alzheimer's disease

Alzheimer's & dementia, 2015-07, Vol.11 (7S_Part_6), p.P276-P277

2015

Link zum Volltext

Verfügbarkeit prüfen

The impact of reference region on the variance of estimated change in PET amyloid standard uptake value ratios measured longitudinally in summit and acction

Alzheimer's & dementia, 2015-07, Vol.11 (7), p.P547-P548

2015

Link zum Volltext

Verfügbarkeit prüfen

RATES OF CHANGE IN BRAIN VOLUME WITH SUBCUTANEOUS BAPINEUZUMAB

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P25-P26

2014

Link zum Volltext

Verfügbarkeit prüfen

AMYLOID BURDEN-RELATED PERFORMANCE DIFFERENCES ON COGNITIVE AND FUNCTIONAL INSTRUMENTS ACROSS ALZHEIMER'S DISEASE PATHOPHYSIOLOGIC STAGES

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P839-P839

2014

Link zum Volltext

Verfügbarkeit prüfen

Pooled biomarker analyses of phase 2 studies of vanutide cridificar vaccine (ACC-001) in mild-to-moderate and early Alzheimer’s disease

Alzheimer's & dementia, 2015-07, Vol.11 (7), p.P276-P277

2015

Link zum Volltext

Verfügbarkeit prüfen

On the construction and estimation of asymmetric GARCH models, and the minimum volume sets for time series

Di, Jianing

2008

Link zum Volltext
ProQuest

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Englisch
(114)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(55)
Female
(33)
Humans
(33)
Animals
(25)
Physical Sciences
(17)
Male
(15)
Cell Biology
(13)
Mice
(12)
Biochemistry & Molecular Biology
(11)
Breast Cancer
(11)
Cancer
(11)
Science & Technology - Other Topics
(11)
Cell Line, Tumor
(10)
Chemistry
(10)
Tumors
(10)
Breast Neoplasms - Pathology
(9)
Metastases
(9)
Oncology
(9)
Rats
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Alzheimer's & Dementia
(15)
Journal Of Alzheimer's Disease
(3)
Life Sciences
(3)
Bioanalysis
(2)
Cell
(2)
Cell Research
(2)
Chemosphere
(2)
Global Challenges
(2)
Journal Of Cellular And Molecular Medicine
(2)
Nature
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder

Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients

A Data-Dependent Approach to Modeling Volatility in Financial Time Series

Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease

On the efficiency of a semi-parametric GARCH model

Effects of Meal Size on the Release of GLP-1 and PYY After Roux-en-Y Gastric Bypass Surgery in Obese Subjects With or Without Type 2 Diabetes

One-step Semiparametric Estimation of the GARCH Model

Continuous event monitoring via a Bayesian predictive approach

P2‐157: The impact of reference region on the variance of estimated change in PET amyloid standard uptake value ratios measured longitudinally in summit and acction

IC‐P‐037: EVALUATION OF CEREBRAL GRAY MATTER AND PONS AS REFERENCE REGIONS FOR AMYLOID PET: RESULTS FROM A BAPINEUZUMAB SUBCUTANEOUS PHASE 2 TRIAL

EVALUATION OF CEREBRAL GRAY MATTER AND PONS AS REFERENCE REGIONS FOR AMYLOID PET: RESULTS FROM A BAPINEUZUMAB SUBCUTANEOUS PHASE 2 TRIAL

IC‐P‐041: EFFICACY AND SAFETY OF MONTHLY SUBCUTANEOUS BAPINEUZUMAB

EFFICACY AND SAFETY OF MONTHLY SUBCUTANEOUS BAPINEUZUMAB

P4‐140: AMYLOID BURDEN‐RELATED PERFORMANCE DIFFERENCES ON COGNITIVE AND FUNCTIONAL INSTRUMENTS ACROSS ALZHEIMER'S DISEASE PATHOPHYSIOLOGIC STAGES

EFFICACY AND SAFETY OF MONTHLY SUBCUTANEOUS BAPINEUZUMAB

P4‐140: AMYLOID BURDEN‐RELATED PERFORMANCE DIFFERENCES ON COGNITIVE AND FUNCTIONAL INSTRUMENTS ACROSS ALZHEIMER'S DISEASE PATHOPHYSIOLOGIC STAGES

IC‐P‐042: RATES OF CHANGE IN BRAIN VOLUME WITH SUBCUTANEOUS BAPINEUZUMAB

P1‐362: EFFICACY AND SAFETY OF MONTHLY SUBCUTANEOUS BAPINEUZUMAB

O4‐04‐04: Pooled biomarker analyses of phase 2 studies of vanutide cridificar vaccine (ACC‐001) in mild‐to‐moderate and early Alzheimer's disease

The impact of reference region on the variance of estimated change in PET amyloid standard uptake value ratios measured longitudinally in summit and acction

RATES OF CHANGE IN BRAIN VOLUME WITH SUBCUTANEOUS BAPINEUZUMAB

AMYLOID BURDEN-RELATED PERFORMANCE DIFFERENCES ON COGNITIVE AND FUNCTIONAL INSTRUMENTS ACROSS ALZHEIMER'S DISEASE PATHOPHYSIOLOGIC STAGES

Pooled biomarker analyses of phase 2 studies of vanutide cridificar vaccine (ACC-001) in mild-to-moderate and early Alzheimer’s disease

On the construction and estimation of asymmetric GARCH models, and the minimum volume sets for time series

Suchergebnisse filtern